Yu XiaoXiao, Lin Xue-Jun, Wang Shuang, Liu XiuHong, Li WeiHua, Kou Bu-Xin, Chai MengYin, Chen DeXi, Liu XiaoNi, Wang XiaoJun
1 Beijing You-An Hospital, Capital Medical University, Beijing, People's Republic of China.
2 Beijing Institute of Hepatology, Beijing, People's Republic of China.
Integr Cancer Ther. 2018 Dec;17(4):1216-1224. doi: 10.1177/1534735418785999. Epub 2018 Jul 6.
Huqizhengxiao (HQZX) decoction is a mixture of traditional Chinese medicines comprising 10 herbs, with inhibitory effects on hepatocarcinoma. The aim of the study is to observe the antitumor efficacy and mechanism of HQZX decoction in nude mice with hepatocellular carcinoma xenografts.
HepG2-luc subcutaneous hepatocarcinoma was established in nude mice. The mice were divided into 5 groups: control, cinobufagin, HQZXS, HQZXM, and HQZXH with doses 13.52, 27.03, and 54.06 g/kg, respectively. HQZX decoction was prepared for intraperitoneal intragastric administration for 3 weeks. Tumor growth was measured with Vernier calipers and in vivo imaging system. α-Fetoprotein (AFP) was determined by radioimmunoassay. Tumor necrosis factor-α (TNF-α) was measured with enzyme-linked immunosorbent assay (ELISA) assay. Telomerase activity was measured with polymerase chain reaction-ELISA. Nuclear mitosis and necrosis were observed with hematoxylin-eosin stain. Apoptotic proteins of caspase-3, Bcl-2, and Bax were examined by Western blot. Signaling molecules of ERK, mTOR, and STAT3 were measured with Luminex assay.
HQZX decoction showed good inhibition of HepG2-luc xenografts. Compared with control group, the relative tumor proliferation rate was less than 60% in the HQZXH and HQZXS. The tumor inhibition rate of HQZXH group reached 52% ± 15%. Relative average optical density values of the HQZXS and HQZXH groups decreased significantly. The mitotic index in HQZXS, HQZXM, and HQZXH groups decreased greatly. Telomerase activity of HQZXS was clearly reduced, and, the caspase-3 expression upregulated in HQZXH group. Bcl-2 expression was downregulated in HQZXS and HQZXH. The ratios of p-ERK/ERK and p-STAT3/STAT3 in HQZXS group were significantly downregulated.
HQZX decoction can clearly inhibit the growth of hepatocellular carcinoma and induce tumor apoptosis. Its antitumor mechanism may be related to reducing telomerase activity and regulating the STAT3 and ERK signal pathway.
胡芪增效(HQZX)汤是由10味中药组成的复方,对肝癌具有抑制作用。本研究旨在观察HQZX汤对人肝癌裸鼠移植瘤的抗肿瘤疗效及其作用机制。
建立人肝癌HepG2-luc裸鼠皮下移植瘤模型。将小鼠分为5组:对照组、华蟾素组、HQZX低剂量组(HQZXS)、HQZX中剂量组(HQZXM)和HQZX高剂量组(HQZXH),给药剂量分别为13.52、27.03和54.06 g/kg。制备HQZX汤,腹腔内灌胃给药3周。用游标卡尺和活体成像系统测量肿瘤生长情况。采用放射免疫分析法测定甲胎蛋白(AFP)。用酶联免疫吸附测定(ELISA)法检测肿瘤坏死因子-α(TNF-α)。采用聚合酶链反应-ELISA法检测端粒酶活性。用苏木精-伊红染色观察细胞核有丝分裂和坏死情况。通过蛋白质免疫印迹法检测半胱天冬酶-3(caspase-3)、Bcl-2和Bax的凋亡蛋白。用Luminex分析法检测细胞外信号调节激酶(ERK)、哺乳动物雷帕霉素靶蛋白(mTOR)和信号转导子与转录激活子3(STAT3)等信号分子。
HQZX汤对HepG2-luc移植瘤具有良好的抑制作用。与对照组相比,HQZXH组和HQZXS组的相对肿瘤增殖率均小于60%。HQZXH组的肿瘤抑制率达52%±15%。HQZXS组和HQZXH组相对平均光密度值显著降低。HQZXS组、HQZXM组和HQZXH组的有丝分裂指数均显著降低。HQZXS组端粒酶活性明显降低;HQZXH组caspase-3表达上调。HQZXS组和HQZXH组Bcl-2表达下调。HQZXS组p-ERK/ERK和p-STAT3/STAT3比值显著下调。
HQZX汤能明显抑制肝癌细胞生长并诱导肿瘤细胞凋亡。其抗肿瘤机制可能与降低端粒酶活性、调节STAT3和ERK信号通路有关。